These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12831061)

  • 1. A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth.
    Arakelyan L; Vainstein V; Agur Z
    Angiogenesis; 2002; 5(3):203-14. PubMed ID: 12831061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.
    Holash J; Wiegand SJ; Yancopoulos GD
    Oncogene; 1999 Sep; 18(38):5356-62. PubMed ID: 10498889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis.
    Hutchinson LG; Gaffney EA; Maini PK; Wagg J; Phipps A; Byrne HM
    J Theor Biol; 2016 Jun; 398():162-80. PubMed ID: 26987523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
    Jain RK
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor angiogenesis: new approaches to cancer therapy].
    Marmé D
    Onkologie; 2001 Feb; 24 Suppl 1():1-5. PubMed ID: 11441305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
    Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY
    Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
    Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
    Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiogenesis, anti-angiogenesis, and tumor suppression].
    Shibuya M
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):285-94. PubMed ID: 12491804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth.
    Hawighorst T; Skobe M; Streit M; Hong YK; Velasco P; Brown LF; Riccardi L; Lange-Asschenfeldt B; Detmar M
    Am J Pathol; 2002 Apr; 160(4):1381-92. PubMed ID: 11943723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of mRNA for vascular endothelial growth factor (VEGF), angiopoietins and their receptors during the peri-implantation period and early pregnancy in marmosets (Callithrix jacchus).
    Rowe AJ; Wulff C; Fraser HM
    Reproduction; 2003 Aug; 126(2):227-38. PubMed ID: 12887279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
    Goede V; Schmidt T; Kimmina S; Kozian D; Augustin HG
    Lab Invest; 1998 Nov; 78(11):1385-94. PubMed ID: 9840613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promises and pitfalls of anti-angiogenic therapy in clinical trials.
    McCarty MF; Liu W; Fan F; Parikh A; Reimuth N; Stoeltzing O; Ellis LM
    Trends Mol Med; 2003 Feb; 9(2):53-8. PubMed ID: 12615038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.
    Kerbel RS; Viloria-Petit A; Klement G; Rak J
    Eur J Cancer; 2000 Jun; 36(10):1248-57. PubMed ID: 10882863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis.
    Schuch G; Kisker O; Atala A; Soker S
    Angiogenesis; 2002; 5(3):181-90. PubMed ID: 12831059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.